Objective To investigate the value of procalcitonin/platelet ratio(PCT/PLT) in evaluating the prognosis of Severe fever with thrombocytopenia syndrome(SFTS). Methods A total of 156 SFTS patients diagnosed in Weihai Central Hospital from January 1, 2020 to January 1, 2022 were collected andassigned into death group and survival group according to the prognosis. the basic data and laboratory indicators of the two groups were compared, the independent risk factors affecting the prognosis of SFTS were screened by univariate and binomial multiple Logistic regression, and the value of different influencing factors on the prognosis of SFTS was evaluated by the area under the receiver operating characteristic(ROC) curve, sensitivity, specificity, accuracy.Results Activated partial thromboplastin time, thrombin time, D-dimer, alanine aminotransferase, serum creatinine, lactate dehydrogenase, aspartate aminotransferase, blood urea nitrogen, activated partial thromboplastin time/platelet, neutrophil count, neutrophil lymphocyte ratio, creatine kinase isoenzyme, procalcitonin, PCT/PLT, as well as the proportion of patients whose nucleic acid quantity were higher than the optimal reference value in the death group was significantly higher than those in the survival group(P<0.05). The proportion of patients with Ca2+, PLT, lymphocyte count higher than the optimal reference value was significantly lower than that in the survival group(P<0.05). Univariate and binomial multiple Logistic regression showed that age, thrombin time, aspartate aminotransferase, lymphocyte count, PCT/PLT, and viral nucleic acid quantification were independent risk factors for the prognosis of SFTS. The best reference value of PCT/PLT was 0.005, and the AUC was 0.828(0.757-0.898). When PCT/PLT was greater than 0.005, the risk of death was increased by 30 times, the sensitivity was 87.1%, and the specificity was 78.4%. Conclusion PCT/PLT can be used as a clinical indicator to evaluate the prognosis of patients with SFTS.